ARTICLE | Company News
Acrux, Eli Lilly deal
March 22, 2010 7:00 AM UTC
Acrux granted Eli Lilly exclusive, worldwide rights to commercialize Axiron, a testosterone metered-dose lotion applied to the underarm to treat hypogonadism. Acrux, which submitted an NDA to FDA for...